The data regarding the role of serum uric acid (SUA) along with subclinical inflammation in the context of hypertensive vascular damage are rather scarce and controversial. Towards this end, we assess the links between SUA, high-sensitivity CRP (hs-CRP), adiponectin and carotid to femoral pulse wave velocity (c-f PWV) in 292 subjects with never-treated stage I-II essential hypertension. On the basis of the median SUA levels (0.31 mmol l À1 ), the study population was divided into subjects with low (n ¼ 149) and high (n ¼ 143) SUA values. By multiple regression analysis, it was revealed that SUA was independently associated with log hs-CRP (R 2 ¼ 0.098; P ¼ 0.02), log adiponectin (R 2 ¼ 0.102; P ¼ 0.03), waist circumference (R 2 ¼ 0.049; P ¼ 0.04), 24-h systolic blood pressure (SBP) (R 2 ¼ 0.179; P ¼ 0.001) and estimated glomerular filtration rate (R 2 ¼ 0.156; b (s.e.) ¼ À0.169 (0.023); P ¼ 0.02). In addition, c-f PWV was independently associated with age (R 2 ¼ 0.116; Po0.0001), waist circumference (R 2 ¼ 0.088; Po0.0001), 24-h SBP (R 2 ¼ 0.167; P ¼ 0.001), log adiponectin (R 2 ¼ 0.07; P ¼ 0.006) and log hs-CRP (R 2 ¼ 0.06; P ¼ 0.034). In conclusion, SUA levels are independently associated with hs-CRP and adiponectin levels but not with c-f PWV in essential hypertensive patients. Increased SUA levels are accompanied by a state of pronounced inflammatory activation and hypoadiponectinemia that significantly impairs the arterial stiffness accelerating the vascular ageing process in this setting.
Introduction
Hyperuricemia is present in 25% of untreated hypertensive subjects, in 50% of subjects under treatment with diuretics and in almost 75% of subjects with malignant hypertension. 1 Although extensive epidemiological data suggest that serum uric acid (SUA) is a relevant marker for cardiovascular disease in different clinical settings including hypertension, it remains debatable whether SUA is an independent risk factor for adverse cardiovascular outcome. [2] [3] [4] [5] Several pathophysiological mechanisms linking SUA to adverse cardiovascular outcome have been proposed, including proliferation of vascular smooth muscle cells, 6 prothrombotic effects mediated by platelet activation, 7 impaired nitric oxide generation and endothelial dysfunction, 8 activation of local renin-angiotensin-aldosterone system 9 and stimulation of inflammatory pathways. 10 Inflammation seems to have a pivotal role in the pathogenesis of hypertension and hypertensive target organ damage. In these lines, we have recently shown that high-sensitivity CRP (hs-CRP) is associated with microalbuminuria, 11 whereas increased hs-CRP and decreased adiponectin levels go together with a state of increased aortic stiffness in hypertensives. 12 In addition, SUA seems to have a bidirectional relationship with inflammation, and it is unclear whether uric acid has anti-oxidant or prooxidant effects. 13 In the same lines, although there is no doubt that hyperuricemia accompanies microalbuminuria, 14 the data regarding its association with left ventricular hypertrophy and aortic stiffness are rather scarce in hypertensive subjects.
Based on the above, we assess in this study the possible associations between SUA, inflammation and vascular dysfunction through its interrelations with hs-CRP, adiponectin and carotid to femoral pulse wave velocity (c-f PWV) in non-diabetic never-treated essential hypertensive subjects.
Materials and methods

Study participants
The study population consisted of 450 consecutive subjects with never-treated newly diagnosed (within the last 2 years) stage I-II essential hypertension who were referred or self-referred to our outpatient hypertension unit within a period of 24 months. The diagnosis of hypertension was based on three outpatient measurements of blood pressure (BP) 4140/ 90 mm Hg and confirmed by daytime ambulatory BP 4135/85 mm Hg. All subjects underwent the usual clinical and laboratory work-up in order to rule out secondary forms of hypertension.
Exclusion criteria included atherosclerotic cardiovascular and vascular disease, and any other clinically significant concurrent systemic disease. We also excluded subjects with diabetes mellitus (fasting glucose 46.94 mmol l À1 ) or impaired glucose tolerance, familial dyslipidemia, atrial fibrillation or conduction abnormalities. Moreover, none of the participants had any history or clinical/laboratory evidence of recent infection, inflammation or underwent any medical treatment (including lipidlowering, hormone replacement and allopurinol therapy) 1 month before entry into the study.
A total of 292 essential hypertensives fulfilling the inclusion criteria of the study comprised the final cohort. All subjects were subjected to medical history assessment, physical examination, ambulatory BP measurement, assessment of aortic stiffness, echocardiographic examinations and estimation of hs-CRP, adiponectin and SUA levels. The study protocol complies with the Declaration of Helsinki, and has been approved by our Institutional Ethics Committee, whereas all participants signed the informed consent.
Office and ambulatory BP measurement Office BP measurements were performed at three consecutive visits in our outpatient clinic 1 week apart. Ambulatory BP measurement was recorded over a working day (Monday to Friday) using the automatic Spacelabs units 90207 (Spacelabs, Redmond, WA, USA). The procedure has been previously described in details. 15 In brief, the cuff was fixed in the non-dominant arm, and the device was set to obtain automatic heart rate and BP readings at 15-min intervals during daytime and at 30-min intervals during nighttime. The 24-h systolic (SBP) and diastolic BP (DBP) values were the mean of the overall 24 h recordings after the artifact editing.
Cardiac echocardiography
The ultrasonographic studies were performed by the same experienced echocardiographer who was blind to the clinical status of the examined subject, according to the recommendations of the American Society of Echocardiography. 16 Aortic stiffness assessment The patients were studied in supine position, having fasted and abstained from smoking and consumption of alcohol and caffeinated beverages during the 12 h before the study. Measurements of c-f PWV were performed by two trained clinicians who were familiar with the technique, in controlled room temperature with constant noise and light intensity, by using a validated non-invasive automatic device (Complior SP; Artech Medical, Pantin, France), as has been described previously. 17 In each patient, five consecutive measurements of c-f PWV were performed and the mean value was obtained.
Anthropometric and biochemical measurements
For each subject, weight, height, waist and hip were measured, while body mass index (BMI) and waist-to-hip ratio were also calculated.
Laboratory determinations
Venous blood sampling was performed between 0800 and 0900 hours, having fasted and abstained from smoking and consumption of alcohol and caffeinated beverages in the last 12 h, to carry out routine tests, as well as to estimate hs-CRP and adiponectin concentrations. Levels of hs-CRP were assessed using validated high-sensitivity assay (Dade Behring Cardio Phase hs-CRP Assay, Marburg, Germany) with intra-assay and inter-assay co-efficient of variation of 3.4 and 2.1%, respectively, and a minimal detectable concentration of 0.175 mg l À1 (ref. 12). Levels of adiponectin were evaluated by a sandwich enzyme-linked immunosorbent assay system (adiponectin ELISA kit, BioVendor, Heidelberg, Germany) with intra-assay and inter-assay co-efficient of variation of 4.5 and 4.1%, respectively, and a minimal detectable concentration of 0.2 mg ml À1 (ref. 12). Finally, uric acid was measured by an enzymatic method and estimated glomerular filtration rate (eGFR) was calculated based on the modification of diet in renal disease formula.
Statistical analysis
STATA statistical software (version 9.0, Stata Corporation, College Station, TX, USA) was used for statistical analysis. All continuous variables are presented as means and standard deviations if their distribution was normal. The Shapiro-Wilk statistic was used to test for any deviation from normality. Because of the skewed distribution, hs-CRP and adiponectin values were logarithmically (log10) transformed before statistical testing. The categorical variables are described with absolute and relative (percentages) frequencies. The distribution of SUA was split by the median (0.31 mmol l À1 ), and high versus low values were defined. Significant differences between the study subgroups were determined using the Student's independent-samples t-test after checking for equality of variance using the Levene's test and analysis of variance. Analysis of covariance was performed in order to detect significant differences in c-f PWV between the study subgroups after adjustment for established confounders. The potential association between categorical variables was tested with the Pearson's w 2 -statistic. Multiple regression models were used to examine the independent associations of SUA and c-f PWV with a number of parameters. To validate our multiple linear regression models, we tested the normality and heteroscedasticity of the residuals produced. Deming's regression was used to test the correlations between SUA and c-f PWV, hs-CRP and adiponectin, owing to their clinical significance and to the potential measurement error. Statistical significance was set at Po0.05 for two-sided tests during linear regression modelling.
Results
On the basis of the median uric acid levels (0.31 mmol l À1 ), the study population was divided into subjects with low (n ¼ 149) and high (n ¼ 143) SUA values.
Patients with high SUA compared with those with low SUA levels presented with greater waist-to-hip ratio by 0.04 (Po0.0001), 24-h SBP by 7 mm Hg (Po0.0001), 24-h DBP by 5 mm Hg (P ¼ 0.001) and lower eGFR values by À2.9 ml min À1 per 1.73m 2 (P ¼ 0.001) ( Table 1 ). In addition, patients with high SUA levels exhibited greater c-f PWV levels by 0.8 m s À1 (Po0.05), higher hs-CRP values by 0.8 mg per 100 ml (Po0.05) and lower adiponectin levels by À1.6 mg ml À1 (Po0.05) ( Table 2 ). Analysis of covariance revealed that the differences in hs-CRP and adiponectin between groups remained statistically significant even after adjustment for age, sex, BMI, waist circumference, 24-h SBP and eGFR (Po0.05 for all cases).
Correlations
In the entire study population, SUA was positively associated with BMI (r ¼ ) ; P ¼ 0.02), whereas age, sex, BMI, 24-h DBP, 24-h heart rate and c-f PWV failed to present such an association (P ¼ NS). Abbreviations: c-f PWV, carotid-femoral pulse wave velocity; eGFR, estimated glomerular filtration rate; hs-CRP, high-sensitivity C-reactive protein; NS, not significant; SUA, serum uric acid; WBC, white blood count. (0.026); P ¼ 0.034), whereas sex, BMI, 24-h DBP, 24-h heart rate, eGFR and SUA failed to present such an association (P ¼ NS). By using Deming's regression analysis, a positive relationship of SUA with c-f PWV and log hs-CRP and a negative relationship of SUA and log adiponectin were revealed (Table 3 , Figure 1 ).
Discussion
The main finding of this study is the independent association of SUA levels with hs-CRP and adiponectin values, but not with c-f PWV, in nevertreated essential hypertensive patients. Increased SUA levels are accompanied by a state of pronounced inflammatory activation and hypoadiponectinemia; the latter significantly impairs the arterial stiffness, accelerating the vascular ageing process in this setting. Whether SUA is a marker or a risk factor for cardiovascular disease is not yet clarified. Similarly, whether elevated SUA is an inducer of inflammation and endothelial dysfunction or a consequence in hypertensive patients remains debatable. In experimental and in vitro systems, uric acid appears to have the ability to induce inflammatory and vascular mechanisms that may contribute to the development of cardiovascular disease. 18 Thus, SUA has been considered to be pro-inflammatory, as it stimulates the synthesis of monocyte chemoattractant protein-1 and causes increase of interleukin-6 and tumour necrosis factor-a. 19 On the other hand, SUA has also been reported to act as an anti-oxidant by binding to reactive oxygen species to form stable nitric oxide donors contributing to almost 50% of the anti-oxidant capacity of blood.
14 In the present cross-sectional study, we found an independent association between SUA and hs-CRP and adiponectin in never-treated hypertensives. Adiponectin is considered to be responsible for reduction in inflammation, stimulation of nitric oxide production and consequently for modulation of endothelial cell function. 20, 21 Previous studies have demonstrated an independent negative association Abbreviations: c-f PWV, carotid-femoral pulse wave velocity; hs-CRP, high-sensitivity C-reactive protein; SUA, serum uric acid.
Uric acid, hs-CRP, adiponectin and arterial stiffness C Tsioufis et al between adiponectin and SUA levels in obese patients and patients with pre-diabetes and impaired glucose tolerance. 22, 23 This independent association was also observed among healthy subjects. 24 Chronic exposure to mild hyperuricemia may be a factor that contributes to microinflammation and hypoadiponectinemia in these individuals; however, an opposite explanation is under consideration.
Our findings that SUA is independently related to haemodynamic load, body size and renal function by means of 24-h SBP, waist circumference and eGFR, respectively, are in accordance with previous studies. 25, 26 Focusing on the relationship of SUA with indices of target organ damage, we had previously shown that increased values of SUA accompanied microalbuminuria but not left ventricular hypertrophy. 14 In this study, SUA was positively related with c-f PWV, but this association ceased to have statistical significance after adjustment for confounders. In the Atherosclerosis Risk in Communities Study, the association of SUA with carotid artery intima-media thickness was negligible, and in a small study (n ¼ 120) conducted in stroke survivors, an independent association between elevated SUA and arterial stiffness was reported.
27 A large-sample-size study showed that SUA was significantly related to c-f PWV in male and female subjects, but the subjects were recruited at a number of institutes with different methods of UA measurement. 28 On the other hand, Cuspidi et al., 29 reported a lack of association between SUA and target organ damage in a selected population of recently diagnosed uncomplicated hypertensives at low prevalence of hyperuricemia. In this study, the absence of the independent associations between SUA and c-f PWV could be attributed, at least partially, to the absence of difference in ambulatory pulse pressure between those with low and high SUA, as well as to the fact that SUA was rather within the normal values. Based on the above, the observed closed association between hs-CRP and adiponectin with both increased SUA and c-f PWV values suggest that subclinical inflammation along with hypoadiponectinemia seems to be a common mediator between increased SUA and increased aortic stiffness. In other words, the SUA-associated inflammatory response and endothelial dysfunction could contribute to augment arterial stiffening in the setting of never-treated hypertension. Towards this end, it is known that pronounced low-grade inflammation in conjunction with hypoadiponectinemia exerts an additive detrimental effect on aortic stiffness, accelerating the vascular ageing process. 12 The cross-sectional nature of our study limits the ability to establish a causal relationship between CRP, adiponectin, SUA and c-f PWV. Another limitation is that we did not estimate augmentation index as a more integrated approach to arterial stiffening. Owing to the fact that we studied nevertreated, middle aged patients who were referred to our outpatient unit, the results could not be directly extendable in other age groups or in patients under anti-hypertensive treatment in the community. However, a potential strength of the study is that ambulatory BP measurements were performed, given the insufficient precision of the sphygmomanometer compared with ambulatory monitoring.
In conclusion, a significant relationship exists between SUA, hs-CRP and adiponectin, but not with c-f PWV in the early stages of hypertension. These findings support the concept that SUA participates, possibly through the mediating effects of subclinical inflammation and hypoadiponectinemia, in the underlying mechanisms leading to hypertensioninduced cardiovascular alterations. Until prospective studies establish the precise prognostic role of SUA, the latter may be considered as a surrogate measure in the evaluation of total cardiovascular risk in essential hypertensive patients.
What is known about topic K Increased serum acid concentrations are accompanied by increased blood pressure levels. K Serum uric acid has a bidirectional relationship with subclinical inflammation, which contributes in the development of target organ damage. K Increased serum uric acid is associated with increased urinary albumin excretion rate in essential hypertensives.
What this study adds K Increased serum acid values are indeed accompanied by increased ambulatory blood pressure levels. K No independent relation exists between uric acid and aortic stiffness. K Serum uric acid is independently associated with highsensitivity C-reactive protein and adiponectin values, providing a possible mechanism to uric acid-related adverse cardiovascular prognosis in essential hypertensives.
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